PTEN and cancer: Higher lifetime risks of developing any cancer were found to be associated with tier 1 PTEN variants, including truncating PTEN variants, whereas lower lifetime risks of any cancer were associated with PTEN promoter variants (eFigure 3 in Supplement 1).